Ireland· IE-PA-EU/1/09/602/1-2
Scintimun 1 mg kit for radiopharmaceutical preparation
A 99mtc-technetium-antigranulozyten antikörper product containing besilesomab, registered in Ireland by Telix Innovations. The same ATC class is registered in 9 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
99mtc-technetium-antigranulozyten antikörper is registered in 9 of 19 countries.
Countries holding a registration under ATC V09HA03 (99mtc-technetium-antigranulozyten antikörper), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 6 of them publish a price we can compare per daily dose
99mtc-technetium-antigranulozyten antikörper · ATC V09HA03
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Besilesomab
- Manufacturer
- Telix Innovations
- Country
- Ireland (IE)
- ATC code
- V09HA03
- ATC class
- 99mTc-Technetium-Antigranulozyten Antikörper
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/09/602/1-2
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
99mtc-technetium-antigranulozyten antikörper in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandScintimunTelix Innovations
- CzechiaSCINTIMUNTelix Innovations, Herstal
- SwitzerlandScintimun, Markierungsbesteckb.e.imaging.ag
- SpainSCINTIMUN 1 mg, EQUIPO DE REACTIVOS PARA PREPARACION RADIOFARMACEUTICATelix Innovations
- FranceSCINTIMUN 1 mg trousse pour préparation radiopharmaceutiqueTELIX INNOVATIONS (BELGIQUE)
- United KingdomScintimun 1mg kit for radiopharmaceutical preparationCurium Pharma UK Ltd
- IcelandScintimunTelix Innovations
- NetherlandsScintimun, 1mg kit voor radiofarmaceutisch preparaatTelix Innovations S.A.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Scintimun
- Liechtenstein · Scintimun
- Norway · Scintimun
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/647fc403-6d26-40b2-ab2a-f5779fdbd0bd GET /v1/drugs/647fc403-6d26-40b2-ab2a-f5779fdbd0bd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kit for radiopharmaceutical preparation",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"V09HA",
"V09HA03"
],
"strength": null,
"pa_number": "EU/1/09/602/1-2",
"substances": [
"Besilesomab"
],
"legal_basis": "Known active substance (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "11/01/2010",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about 99mtc-technetium-antigranulozyten antikörper.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.